drugset / Trial / NCT00321074

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts

NCT00321074

Phase 3 Completed 101 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the safety and efficacy of two different tacrolimus based immunosuppressive regimens, one in combination with daclizumab, the other in combination with steroids, in recipients of suboptimal livers. Pharmacokinetics of tacrolimus and bile composition will be measured in a subgroup of patients.

Timeline

Start
2005-05
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule

Indications

No indication recorded.